@Snail said:
@Mageman said:
@Snail said:
I don't operate with those assumptions, though you keep implying that.
The desire to feel ecstatic (especially present when one is depressed) can more easily lead to lack of control in the taking of this drug, than in the consumption of coffee. This independently of whatever dependency quotients you can throw at me.
I had already said that though. So I've reached the conclusion that I've already said what I had to say, and if I argue against that post any more extensively we'd going in circles.
You can mediate the depression, and as more recently showed with pure mdma it does not even have to really occur on any meaningful/big level. One trip of mdma does not ''break you'' and make you crave for more, that is silly.
You keep misinterpreting what I say. If you are to reply to me again please devote more time to reading my post, because, again, I am not saying that at all.
I am not saying that the depression happens because of MDMA. You seem to have misunderstood this? I am asking you to hypothesize a person who is depressed because, say, he or she was dumped by a significant other, or due to the loss of a family member. Shit happens to people.
You can meditate a depression. You can also take ecstasy and instantly feel better. To someone acquainted with the drug, how tempting is that?
I am not saying that one trip of MDMA "breaks you", I have no idea where you found that in my posts. I am talking about long-term consumption, led to significant increase by a state of depression.
I must agree. MDMA is not something everyone should be taking every weekend to party with necessarily.
"The long-term effects most frequently reported included the development of tolerance to MDMA (59%), impaired ability to concentrate (38%), depression (37%) and ‘feeling more open towards people’ (31%)."
http://onlinelibrary.wiley.com/doi/10.1002/hup.529/abstract;jsessionid=42A8E9824DBC91B90137E4BD034AFE0E.d03t02
Acute, sub-acute and long-term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users
- Suzanne L. Verheyden,
- John A. Henry,
- H. Valerie Curran
Article first published online: 1 OCT 2003
DOI: 10.1002/hup.529
Human Psychopharmacology: Clinical and Experimental
, Issue 7,pages 507–517, October 2003
Log in to comment